Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.060
-0.010 (-0.93%)
May 12, 2025, 4:00 PM - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $33.10 million as of May 12, 2025. Its market cap has decreased by -23.38% in one year.
Market Cap
33.10M
Enterprise Value
28.30M
1-Year Change
-23.38%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $33.10M, a decrease of -65.08%. That is a compound annual growth rate of -15.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 33.10M | -36.10% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |